Vaishali Pharma Limited (VAISHALI) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.22x

Vaishali Pharma Limited (VAISHALI) has a Cash Flow Reinvestment Rate of 0.22x as of September 2025, reinvesting Rs4.60 Million (capex Rs4.60 Million ) from operating cash flow of Rs20.46 Million. Check VAISHALI cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.22x
(Capex + Investments) / Operating CF

Total Reinvested

Rs4.60 Million
Capex + Investments

Operating Cash Flow

Rs20.46 Million
INR

Capital Expenditures

Rs4.60 Million
INR

Vaishali Pharma Limited Cash Flow Reinvestment Rate (2013–2024)

Historical reinvestment intensity for Vaishali Pharma Limited across 9 annual periods. Explore VAISHALI cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Vaishali Pharma Limited (2013–2024)

Year-by-year capital reinvestment analysis for Vaishali Pharma Limited. For live market cap and broader valuation context, see Vaishali Pharma Limited market cap and net worth.

Year Reinvestment Rate Total Reinvested (INR) Operating CF Capex YoY Change
2024 1.63x Rs13.14 Million Rs8.07 Million Rs1.11 Million ▲ +203.5%
2023 0.54x Rs5.79 Million Rs10.80 Million Rs2.97 Million ▼ -58.7%
2022 1.30x Rs17.12 Million Rs13.19 Million Rs8.65 Million ▲ +1004.7%
2021 0.12x Rs2.36 Million Rs20.11 Million Rs1.26 Million ▲ +425.8%
2020 0.02x Rs719.25K Rs32.19 Million Rs526.04K ▼ -94.4%
2019 0.40x Rs11.39 Million Rs28.48 Million Rs2.96 Million ▲ +469.7%
2017 0.07x Rs598.00K Rs8.52 Million Rs35.00K ▲ +280.3%
2016 0.02x Rs847.00K Rs45.88 Million Rs847.00K ▲ +469.9%
2013 0.00x Rs123.00K Rs37.97 Million Rs123.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow